Skip to content

Peptide Formulation Science

Peptide drugs present unique formulation challenges due to their structural complexity, chemical lability, and propensity for aggregation. This section provides the scientific foundations for designing stable, effective peptide formulations.

๐Ÿงช

Peptide Formulation Stability

Chemical and physical degradation pathways โ€” deamidation, oxidation, hydrolysis, aggregation โ€” and strategies to maintain peptide stability in formulation.

โ†’ Deamidation of asparagine and glutamine
โ†’ Methionine and cysteine oxidation
โ†’ Forced degradation study design
โ„๏ธ

Lyophilization Formulation Design

Freeze-drying cycle development, cryoprotectant and lyoprotectant selection, glass transition temperature, and cake appearance optimization.

โ†’ Tg' and collapse temperature
โ†’ Annealing step optimization
โ†’ Residual moisture specification
โš–๏ธ

pH and Buffer Selection for Peptide Formulations

pH-solubility profiles, buffer catalysis of degradation, ionic strength effects, and rational buffer selection for peptide stability.

โ†’ pH-rate profiles for peptide degradation
โ†’ Buffer species and concentration optimization
โ†’ Isoelectric point and solubility
๐Ÿงฉ

Peptide Aggregation Prevention

Mechanisms of peptide aggregation โ€” nucleation, fibril formation, amorphous aggregation โ€” and formulation strategies including surfactants and amino acid excipients.

โ†’ Amyloid fibril formation mechanisms
โ†’ Surfactant stabilization (polysorbates)
โ†’ Arginine and other aggregation suppressors
๐Ÿง‚

Excipients for Peptide Formulations

Functional classification of pharmaceutical excipients โ€” bulking agents, tonicifiers, preservatives, antioxidants โ€” and their compatibility with peptide drugs.

โ†’ Mannitol, trehalose, and sucrose
โ†’ Antimicrobial preservative selection
โ†’ Excipient compatibility screening